SpringerLink
Log in

Pharmacological Treatment of Painful Nerve Entrapment Syndrome

  • Chapter
Peripheral Nerve Entrapments

Abstract

One of the common complaints of nerve entrapment syndrome (NES) is neuropathic pain. Timely and effectively controlling pain is an important goal of NES treatment. Pharmacological treatment of painful NES provides noninvasive and effective pain relief, in both acute and chronic NES settings. It can be utilized as independent therapy or as an adjunct therapy along with interventional procedures or surgical treatment.

The most commonly used pharmacological treatment is discussed in this chapter, including non-opioid and opioid regimens, systemic, and topical agents.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
EUR 29.95
Price includes VAT (Germany)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
EUR 181.89
Price includes VAT (Germany)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
EUR 228.98
Price includes VAT (Germany)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info
Hardcover Book
EUR 246.09
Price includes VAT (Germany)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Bare AA, Haddad SL. Nerve entrapment syndromes. In: Thordarson DB, editor. Foot and ankle. Philadelphia: Lippincott, Willams & Wilkins; 2004. p. 79–97.

    Google Scholar 

  2. Morganti CM, McFarland EG, et al. Saphenous neuritis: a poorly understood cause of medial knee pain. J Am Acad Orthop Surg. 2002;10:130–7.

    Article  PubMed  Google Scholar 

  3. Pecina M, Markiewitz AD, et al. Tunnel syndrome in athletes in tunnel syndromes: peripheral nerve compression syndrome. New York: Taylor & Francis; 2001. p288.

    Google Scholar 

  4. Flaigan RM, DiGiovanni BF. Peripheral nerve entrapments of the lower leg, ankle, and foot. Foot Ankle Clin N Am. 2011;16:255–74.

    Article  Google Scholar 

  5. Leon-Casasola OD. New developments in the treatment algorithm for peripheral neuropathic pain. Pain Med. 2011;12:S100–8.

    Article  PubMed  Google Scholar 

  6. Dworkin RH, O’Connor AB, et al. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain. 2007;132:237–51.

    Article  CAS  PubMed  Google Scholar 

  7. McCormack K. Non-steroidal anti-inflammatory drugs and spinal nociceptive processing. Pain. 1994;59:9.

    Article  CAS  PubMed  Google Scholar 

  8. Gajraj N. Cyclooxygenase-2 inhibitors. Anesth Analg. 2003;96:1720–38.

    Article  CAS  PubMed  Google Scholar 

  9. Laneuvill O, et al. Differential inhibition of human prostaglandin endoperoxide H synthases-1 and -2 by nonsteroidal anti-inflammatory drugs. J Pharmacol Exp Ther. 1994;271:927–34.

    Google Scholar 

  10. Roelofs PD, Deyo RA, et al. Nonsteroidal anti-inflammatory drugs for low back pain: an updated Cochrane review. Spine (Phila PA 1976). 2008;33L:1766.

    Article  Google Scholar 

  11. Solomon SD, Hawk E, et al. Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials: the cross trial safety analysis. Circulation. 2008;117:2104–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Ballantyne JC, Barna SA. Nonsteroidal anti-inflammatory drugs. In: Ballantyne JC, editor. The Massachusetts General Hospital handbook of pain management. Philadelphia: Lippincott Williams & Wilkins; 2006. p. 97–103.

    Google Scholar 

  13. Traynor LM, Thiessen CN, Traynor AP. Pharmacotherapy of fibromyalgia. Am J Health-Syst Pharm. 2011;68:1307.

    Article  CAS  PubMed  Google Scholar 

  14. Sullivan M, Robinson JP. Antidepressant and anticonvulsant medication for chronic pain. Phys Med Rehabil Clin N Am. 2006;17:381–400.

    Article  PubMed  Google Scholar 

  15. Singleton JR, Smith AG. The diabetic neuropathies: practical and rational therapy. Semin Neurol. 2012;32:196–203.

    Article  PubMed  Google Scholar 

  16. Saarto T, Wiffen PJ. Antidepressants for neuropathic pain: a Cochrane review. J Neurol Neurosurg Psychiatry. 2010;81:1372.

    Article  PubMed  Google Scholar 

  17. Sindrup SH, Otto M, et al. Antidepressants in the treatment of neuropathic pain. Basic Clin Pharmacol Toxicol. 2005;96:399.

    Article  CAS  PubMed  Google Scholar 

  18. Max MB, Muir J, et al. Effects of desipramine. Amitriptyline and fluoxetine on pain relief in diabetic neuropathy. N Engl J Med. 1996;326:1250.

    Article  Google Scholar 

  19. Collins SL, Moore RA, et al. Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: a quantitative systematic review. J Pain Symptom Manage. 2000;20:449.

    Article  CAS  PubMed  Google Scholar 

  20. Deffois A, Carter C, et al. Inhibition of synaptosomal veratridine-induced sodium influx by antidepressants and neuroleptics used in chronic pain. Neurosci Lett. 1996;220:117.

    Article  CAS  PubMed  Google Scholar 

  21. Boyle J, Kerr D, et al. Randomized, placebo-controlled comparison of amitriptyline, duloxetine, and pregabalin in patients with chronic diabetic peripheral neuropathic pain: impact on pain, polysomnographic sleep, daytime functioning, and quality of life. Diabetes Care. 2012;35:2451.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Tanenberg RJ, Malcolm SK, et al. Duloxetine, pregabalin, and duloxetine plus gabapentin for diabetic peripheral neuropathic pain management in patients with inadequate pain response to gabapentin: an open-label, randomized, noninferiority comparison. Mayo Clin Proc. 2011;86:615.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Gilron I, Lemay J, et al. Pregabalin for peripheral neuropathic pain: a multicenter, enriched enrollment randomized withdrawal placebo-controlled trial. Clin J Pain. 2011;27:185.

    Article  PubMed  Google Scholar 

  24. Backnonia M, Beydoun A, Edwards KR, et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA. 1998;280(21):1831–6.

    Article  Google Scholar 

  25. Rice AS, Maton S. Gabapentin in postherpetic neuralgia: a randomized, double blind, placebo controlled study. Pain. 2001;94:215.

    Article  CAS  PubMed  Google Scholar 

  26. Serpell MG. For the neuropathic pain study group: gabapentin in neuropathic pain syndromes: a randomized, double-blind, placebo-controlled trial. Pain. 2002;99:557.

    Article  CAS  PubMed  Google Scholar 

  27. Gronseth G, Cruccu G, et al. Practice parameter: the diagnostic evaluation and treatment of trigeminal neuralgia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the European Federation of Neurological Societies. Neurology. 2008;71:1183.

    Article  CAS  PubMed  Google Scholar 

  28. Martin WJJ, Forouzanfar T. The efficacy of anticonvulsants on orofacial pain: a systematic review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;111:627.

    Article  PubMed  Google Scholar 

  29. Arezzo JC, Rosenstock J, Lamoreaux L, Pauer L. Efficacy and safety of pregabalin 600mg/day for treating painful diabetic peripheral neuropathy: a double-blind placebo-controlled trial. BMC Neurol. 2008;8:33.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Drug information website. www.uptodate.com/lexicomp.

  31. Von Korff M, Kolodny A, et al. Long-term opioid therapy reconsidered. Ann Intern Med. 2011;155:325.

    Article  Google Scholar 

  32. Ballantyne JC, Mao J. Opioid therapy for chronic pain. N Engl J Med. 2003;349:1943.

    Article  CAS  PubMed  Google Scholar 

  33. Chou R, Fanciullo GJ, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10:113.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Furlan AD, Sandoval JA, et al. Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. CMAJ. 2006;174:1589.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Foley KM. Opioids and chronic neuropathic pain. N Engl J Med. 2003;348:1279.

    Article  PubMed  Google Scholar 

  36. Duhmke RM, Cornblath DD, et al. Tramadol for neuropathic pain. Cochrane Database Syst Rev. 2004;2:CD003276.

    Google Scholar 

  37. Schwartz S, Etropolski M, Shapiro DY, et al. Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trial. Curr Med Res Opin. 2011;27:151–62.

    Article  CAS  PubMed  Google Scholar 

  38. Cote J, Montgomery L. Sublingual buprenorphine as an analgesic in chronic pain: a systematic review. Pain Med. 2014;15:1171.

    Article  PubMed  Google Scholar 

  39. Li X, Kosten TR, et al. Buprenorphine in the treatment of opioid addiction: opportunities, challenges and strategies. Expert Opin Pharmacother. 2014;15:2263.

    Article  CAS  PubMed  Google Scholar 

  40. Buprenorphine: drug information. http://www.uptodate.com/contents/buprenorphine-drug-information.

  41. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: part 2 - guidance. http://www.guideline.gov/content.aspx?id=38257&search=opioid.

  42. Managing chronic non-terminal pain in adults including prescribing controlled substances. http://www.guideline.gov/content.aspx?id=25657&search=opioid.

  43. Chu LF, Angst MS, et al. Opioid-induced hyperalgesia in humans: molecular mechanisms and clinical considerations. Clin J Pain. 2008;24:479.

    Article  PubMed  Google Scholar 

  44. Fishbain DA, Cole B, et al. Do opioids induce hyperalgesia in humans? An evidence-based structured review. Pain Med. 2009;10:829.

    Article  PubMed  Google Scholar 

  45. Brush DE. Complications of long-term opioid therapy for management of chronic pain: the paradox of opioid-induced hyperalgesia. J Med Toxicol. 2012;8:387–92.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Zur E. Topical treatment of neuropathic pain using compounded medications. Clin J Pain. 2014;30(1):73–91.

    Google Scholar 

  47. Derry S, Moore RA. Topical capsaicin (high concentration) for chronic neuropathic pain in adults. Cochrane Database Syst Rev. 2013;2:CD 007393.

    Google Scholar 

  48. Simpson DM, Brown S, Tobias JK, Vanhove GF. NGX-4010, a capsaicin 8 % dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: results of a 52-week open-label study. Clin J Pain. 2014;30(2):134–42.

    Google Scholar 

  49. McCarberg BH, Argoff CE. Topical diclofenac epolamine patch 1.3% for treatment of acute pain caused by soft tissue injury. Int J Clin Pract. 2010;64:1546–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Vorobeychik Y, Chen L. Combination therapy for neuropathic pain – a review of current evidence. CNS Drugs. 2011;25:1023.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Anesthesiology and Pain Medicine, University of Washington Medical Center, 4225 Roosevelt Way NE, Seattle, WA, 98105, USA

    Tiffany Zhang MD, PhD

Authors
  1. Tiffany Zhang MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tiffany Zhang MD, PhD .

Editor information

Editors and Affiliations

  1. Pain and Headache Center, Anchorage, AK, USA

    Andrea M. Trescot MD, ABIPP, FIPP (Medical Director) (Medical Director)

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Zhang, T. (2016). Pharmacological Treatment of Painful Nerve Entrapment Syndrome. In: Trescot, A.M. (eds) Peripheral Nerve Entrapments. Springer, Cham. https://doi.org/10.1007/978-3-319-27482-9_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-27482-9_4

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-27480-5

  • Online ISBN: 978-3-319-27482-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation